Coverage by Ladenburg Thalmann: BUY with target price of CHF 17 (150% above today's price) http://www.addexpharma.com/fileadmin/user_upload/Media_Exposure/Ladenburg_Thalmann_28_FEB_2012.pdf Next R&D results expected end March.